← SynDRA

LAPACHONE

SynDRA canonical compound SYN0000816 — structure-anchored drug synonym record

All known targets

• TOP1
• E2F1
• IDO1
• SIRT1
• TDO2

Mechanisms of action (all sources)

• topoisomerase inhibitor
• SIRT1 MODULATOR
• TOP1 MODULATOR

Cross-references

• PubChem CID: 3885
• ChEMBL: CHEMBL15192
• DrugBank: DB11948
• ChEBI: 10429
• KEGG: C10367
• TTD: D0TU7V

Synonyms

• .beta.-lapachone
• ARQ-501
• Beta-lapachone
• Beta-lap-wj
• Lapachone, beta-
• MB-12066
• NSC-26326
• NSC-629749
• B-lapachone (obesity), Mazence
• Beta-lapachone (obesity), Mazence
• Beta-Lapachone
• ARQ 501
• SL 11001
• A-lapachone
• LAPACHONE, BETA
• AK-693/21096016
• 2,2-dimethyl-3,4-dihydrobenzo[h]chromene-5,6-dione
• 3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione
• 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-B]pyran-5,6-dione
• NSC 26326
• 6N4FA2QQ6A
• NSC 629749
• 2H-Naphtho[1,2-b]pyran-5,6-dione, 3,4-dihydro-2,2-dimethyl-
• NSC26326
• NSC629749
• ARQ501
• CHEBI:10429
• 2H-Naphtho(1,2-b)pyran-5,6-dione, 3,4-dihydro-2,2-dimethyl-
• 2,2-dimethyl-3,4-dihydrobenzo(h)chromene-5,6-dione
• RefChem:567893
• DTXCID50119510
• 2,2-Dimethyl-3,4-dihydro-2H-benzo[h]chromene-5,6-dione
• .beta.-Lapachone
• MFCD01712233
• ARQ-501 (beta lapachone)
• MB12066
• ARQ-501;NSC-26326
• b-Lapachone (90%)